TPD52 Polyclonal Antibody

Rabbit Anti-TPD52 Polyclonal Antibody

Product Specifications

Background

The tumor protein D52 (TPD52) family consists of three members, TPD52, TPD52L1 (D53), and TPD52L2 (D54) . These small coiled-coil motif bearing proteins interact in hetero- and homomeric fashion. The TPD52 gene maps to chromosome 8q21, and due to amplification, shows frequent overexpression in prostate and breast carcinomas. TPD52 bound to annexin VI in a Ca2+-dependent manner, suggesting that these molecules may act in concert to regulate secretory processes in plasma cells.

CAS Number

9007-83-4

Product Name Alternative

TPD52; Tumor protein D52; Protein N8

Gene ID

7163

Accession Number

P55327

Reactivity

Human, Mouse

Immunogen

Synthesized peptide derived from the Internal region of human TPD52 at AA range: 10-90

Clonality

Polyclonal

Tag

Tumor protein D52

Applications

IHC, IF, ELISA

Field of Research

Cancer#Cell Biology #Epigenetics

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

TPD52 Polyclonal Antibody detects endogenous levels of TPD52 protein.

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:100-1:300; ELISA 1:40000; IF 1:50-200